Improvement of mouse brain mitochondrial function after deprenyl treatment

Neuroscience

Volumn 144, Issue 2, 2007, Pages 685-693

  Czerniczyniec, A ^a   Bustamante, J ^a   Lores Arnaiz, S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

brain mitochondria; hydrogen peroxide; mitochondrial permeability transition; nitric oxide synthase; oxygen uptake

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CALCIUM; CYTOCHROME C OXIDASE; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE; SELEGILINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; ENZYME ACTIVITY; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE PERMEABILITY TRANSITION; MITOCHONDRIAL RESPIRATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE DIPHOSPHATE; ANIMALS; BECLOMETHASONE; BLOTTING, WESTERN; BRAIN; CALCIUM; DRUG INTERACTIONS; HYDROGEN PEROXIDE; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NITRIC OXIDE SYNTHASE; OXYGEN CONSUMPTION; PERMEABILITY; SELEGILINE; SUBCELLULAR FRACTIONS; SUBMITOCHONDRIAL PARTICLES;

EID: 33845192625     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.09.050     Document Type: Article

References (37)

1. Alper G., Girgin F.K., Ozgönül M., Mentes G., and Rezos B. MAO inhibitors and oxidant stress in aging brain tissues. Eur Neuropsychopharmacol 9 (1999) 247-252
2. Azonne G.F., Pietrobon D., and Zoratti M. Determination of the proton electrochemical gradient across biological membranes. Curr Top Bioenergy 13 (1984) 1-77
3. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 105 (1984) 429-435
4. Boveris A., Costa L.E., Cadenas E., and Poderoso J.J. Regulation of mitochondrial respiration by adenosine diphosphate, oxygen and nitric oxide. Methods Enzymol 301 (1999) 188-198
5. Boveris A., Lores Arnaiz S., Bustamante J., Alvarez S., Valdez L., Boveris A.D., and Navarro A. Pharmacological regulation of mitochondrial nitric oxide synthase. Methods Enzymol 359 (2002) 328-339
6. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome oxidase. Biochim Biophys Acta 1504 (2001) 46-57
7. Brown G.C. NO says yes to mitochondria. Science 299 (2003) 838-839
8. Bustamante J., Bersier G., Aron-Badin R., Cymeryng C., Parodi A., and Boveris A. Sequential NO production by mitochondria and endoplasmic reticulum during induced apoptosis. Nitric Oxide 6 (2002) 333-341
9. Bustamante J., Nutt L., Orrenius S., and Gogvadze V. Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol Appl Pharmacol 207 2 Suppl (2005) 110-116
10. Cleeter M.W.J., Cooper J.M., Darley-Usmar V.M., Moncada S., and Shapira A.H.V. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain. Implications for neurodegenerative diseases. FEBS Lett 345 (1994) 50-54
11. Czerniczyniec A., Bustamante J., and Lores Arnaiz S. Modulation of brain mitochondrial function by deprenyl. Neurochem Int 48 (2006) 235-241
12. Ghafourifar P., and Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett 418 (1997) 291-296
13. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J 332 Pt 3 (1998) 673-679
14. Giulivi C., Poderoso J.J., and Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 273 (1998) 11038-11043
15. Kanai A.J., Pearce L.L., Clemens P.R., Birder L., Van Bibber M.M., Choi S.Y., de Groat W.C., and Peterson J. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A 98 (2001) 14126-14131
16. Kiray M., Uysal N., Sonmez A., Acikgoz O., and Gonenc S. Positive effects of deprenyl and estradiol in aged female rat brains. Neurosci Lett 354 (2004) 225-228
17. Kitani K., Minami C., Yamamoto T., Kanai S., Ivy G.O., and Carrillo M.C. Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use. Ann N Y Acad Sci 959 (2002) 295-307
18. Knoll J., and Magyar K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5 (1972) 393-408
19. Kroemer G., Dallaporta B., and Resche-Rigon M. The mitochondrial death/life regulators in apoptosis and necrosis. Annu Rev Physiol 60 (1998) 619-642
20. Lacza Z., Puskar M., Figueroa J.P., Zhang J., Rajapakse N., and Busua D.W. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic Biol Med 31 (2001) 1609-1615
21. Lee C., Lee C.S., Ko H.H., Song J.H., and Han E.S. Effect of R-(-)-deprenyl and harmaline on dopamine and peroxynitrite-induced membrane permeability transition in brain mitochondria. Neurochem Res 27 3 (2002) 215-224
22. Lores Arnaiz S., Coronel M.F., and Boveris A. Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide Biol Chem 3 (1999) 235-243
23. Lores Arnaiz S., D'Amico G., Czerniczyniec A., Bustamante J., and Boveris A. Brain mitochondrial nitric oxide synthase: in vitro and in vivo inhibition by chlorpromazine. Arch Biochem Biophys 430 (2004) 170-177
24. Lores Arnaiz S., D'Amico G., Paglia N., Arismendi M., Basso N., and Lores Arnaiz M.R. Enriched environment, nitric oxide production and synaptic plasticity prevent the aging-dependent impairment of spatial cognition. Mol Asp Med 25 (2004) 91-101
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
26. Maruyama M., and Naoi M. Neuroprotection by (-)deprenyl and related compounds. Mech Ageing Dev 111 (1999) 189-200
27. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 2 (1999) 123-144
28. Petit P.X., Lecoeur H., Zorn E., Dauguet C., Mignotte B., and Gougeon M.L. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130 1 (1995) 157-167
29. Poderoso J.J., Carreras M.C., Lisdero C.L., Riobó N.A., Schöpfer F., and Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 328 (1996) 85-92
30. Simon L., Szilagyi S., Bori Z., Telek G., Magyar K., and Nagy Z. Low dose (-) deprenyl is cytoprotective: It maintains mitochondrial membrane potential and eliminates oxygen radicals. Life Sci 78 (2005) 225-231
31. Tatoyan A., and Giulivi C. Purification and characterization of a nitric oxide synthase from rat liver mitochondria. J Biol Chem 273 (1998) 11044-11048
32. Thomas T. Monoamine oxidase B inhibitors in the treatment of Alzheimer's disease. Neurobiol Aging 21 (2000) 343-348
33. Tyler D.D., and Gonze J. The preparation of thyroid and thymus mitochondria. Methods Enzymol 10 (1967) 101-103
34. Wadia J.S., Chalmers-Redman R.M., Ju W.J., Carlile G.W., Phillips J.L., Fraser A.D., and Tatton W.G. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: Time course and modification by (-)-deprenyl. J Neurosci 18 (1998) 932-947
35. Weissbach H., Smith T.E., Daly J.W., Witkop B., and Udenfriend S. A rapid spectrophotometric assay of monoamine oxidase based on the rate of disappearance of kynuramine. J Biol Chem 235 2 (1960) 1160-1163
36. Yonetani T. Cytochrome oxidase: beef heart. Methods Enzymol 10 (1967) 332-335
37. Zhang Y., and Herman B. Ageing and apoptosis. Mech Ageing Dev 123 (2002) 245-260